- Abstract:
- There is a necessity to better characterize uveal melanoma (UM) tumors according to their metastasis potential at an early stage. In this study we report the identification of potential biomarkers by a combination of proteomics-related approaches: the characterization of UM cell secretomes, the analysis of UM autoantibodies, and the differential depleted serum proteome analysis. We describe a possible role of cathepsin D, syntenin, and gp100 in UM as potential biomarkers.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
- Publisher:
- American Society for Biochemistry and Molecular Biology Publisher's website
- Journal:
- Journal of Proteome Research Journal website
- Volume:
- 6
- Issue:
- 7
- Pages:
- 2802-2811
- Publication date:
- 2006-12-23
- DOI:
- EISSN:
-
1535-3907
- ISSN:
-
1535-3893
- URN:
-
uuid:584a9cce-e1bc-4f7e-beb6-1995f5daf826
- Source identifiers:
-
100277
- Local pid:
- pubs:100277
- Copyright holder:
- American Chemical Society
- Copyright date:
- 2006
- Notes:
- © 2007 American Chemical Society. The final version is available online from the American Chemical Society at: [10.1021/pr070021t]
Journal article
Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.
Actions
Authors
Funding
Oxford Glycobiology Institute Endowment
More from this funder
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record